United States Self-Monitoring Blood Glucose (SMBG) Market to Surpass USD 4.6 Billion Valuation Through 2027

February 19, 2021


According to the research report titled ‘United States Self-Monitoring Blood Glucose (SMBG) Market Analysis 2015 - 2020 and Industry Forecast 2021 – 2027’, available with Market Study Report LLC, United States self-monitoring blood glucose (SMBG) market valuation is expected to reach USD 4.6 billion by the end of 2027.
 

The report states that United States self-monitoring blood glucose (SMBG) market growth is driven by increasing risk factors leading to diabetes, booming elderly population, rapid approval of innovative, user-friendly, and technological advancements products, along with rising pool suffering from diabetes.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3140355/
 

The research report on United States self-monitoring blood glucose (SMBG) market sheds light on all key trends, primary growth drivers, as well as challenges that will shape the industry dynamics over the predicted timeframe. It also includes recent industry developments and deals in the business sphere, along with partnership deals, licensing agreement, mergers & acquisitions, and collaboration deals.
 

The document contains reimbursement patterns of the United States self-monitoring blood glucose (SMBG) industry, along with detailed insights into the regulatory framework. It further investigates each major player based on factors like recent developments, key marketed products, and business overview. Moreover, it entails granular assessment of the United States blood glucose meter, lancets, and test strips users volume and forecast to 2027.
 

The competitive landscape of United States self-monitoring blood glucose (SMBG) industry sphere is defined by Osang Healthcare Co., Ltd., Ypsomed Holding AG, Medtronic plc, Omron Healthcare Inc., i-SENS Inc., B. Braun Holding GmbH & Co. KG, Smart Meter LLC, One Drop (Informed Data Systems Inc.), DarioHealth Corp., Simple Diagnostics, Trividia Health Inc., Prodigy Diabetes Care LLC, Entra Health (Acquired by CRF Health), Abbott Diabetes Care, LifeScan Inc., and Genesis Health Technologies among others.

Chat with us